Skip to main content
Home

oAv Menu

  • Home
  • Patient Care Center
  • Clinical Trials
  • Providers
    • Therapeutics
    • People
    • Places
  • Community Center
    • Community Stories
    • Social Media
    • Community Content
    • Financial Assistance
  • News
    • Community Events
    • Clinical Trials and Research
    • Business
    • News People
    • Happenings
    • Spotlight
    • Fundraising Events
  • Trusted Resources
    • Education
    • Videos & Visuals
  • Event Calendar
  • Login
  • Search

Trusted Resources

  • Education
  • Videos & Visuals
  1. Home
  2. Trusted Resources
American College of Cardiology
Mar 29, 2024
Cardiac Amyloidosis and How to Stop Missing the Diagnosis
Read more
Springer Link
Mar 28, 2024
A rare clinical case of systemic AA amyloidosis with cardiac involvement complicating ankylosing spondylitis: a case report
Read more
Real-World Effectiveness
Mar 23, 2024
Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Variant Transthyretin Amyloid Cardiomyopathy
Read more
U.S FOOD & DRUG ADMINISTRATION
Mar 20, 2024
Guidance Documents for Rare Disease Drug Development
Read more
AJKD
Mar 19, 2024
2024 Update on Classification, Etiology, and Typing of Renal Amyloidosis: A Review
Read more
National Library of Medicine
Mar 18, 2024
Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management
Read more
Alnylam Pharmaceuticals, Inc.
Mar 13, 2024
Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited and Rapidly Progressive Disease
Read more
bmj Journals
Feb 29, 2024
Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare professionals
Read more
radcliffe cardiology
Feb 28, 2024
Cardiac Amyloidosis: Emerging Diagnostic and Treatment Approaches
Read more
U.S FOOD & DRUG ADMINISTRATION
Feb 14, 2024
FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient’s Voice in Medical Product Development and Regulatory Decision Making
Read more

Pagination

  • « First First page
  • ‹‹ Previous page
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • ›› Next page
  • Last » Last page
Subscribe to

Newsletter

Stay informed - subscribe to our newsletter.
The subscriber's email address.

Expert and Community Perspectives on Attruby®

In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related to Attruby™ (acoramidis). This expert-led discussion explores the clinical data, the patient perspective, and what lies ahead for those considering or currently taking Attruby.

Subscribe

Featured Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Footer menu

  • Home
  • About us
  • Video
  • Galleries
  • Contact
  • Login
  • Privacy Policy
  • Privacy Reminder
  • Terms of use
  • FAQ
  • Code of Conduct

© 2025 Somebody To Talk To, Inc.

Join us on